Clinical Trial Update: A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PF-04447943 to placebo in mild to moderate Alzheimer's disease has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PF-04447943 (PF-04447943)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-11-19